Answers are grounded in this paper and cite their sources.
Review highlights novel therapies for bladder, prostate, and kidney cancers, suggesting significant advancements in treatment.
Several new clinical trial results were presented at the 2025 European Society for Medical Oncology Congress in Berlin, some of which may change the therapeutic landscape for bladder, prostate, and kidney cancers. In this review, the most important urooncological studies are highlighted, with a focus on those featured during the Congress Presidential Session.
No takes yet. Share an insight, caveat, or question.
Sigorski et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: